Article Details

CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status

Retrieved on: 2020-12-03 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

CVRx® BAROSTIM Therapy Receives CMS Approval for Transitional Pass-Through Payment Status. View article details on hiswai:

Excerpt

TPT payment is intended to facilitate the use of newly FDA-approved <b>medical</b> <b>devices</b>, drugs, and biologics across all fields of medicine and to boost ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up